Parent Intervention for Psychiatrically-Hospitalized Youth
Launched by STANFORD UNIVERSITY · Mar 11, 2021
Trial Information
Current as of July 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new program designed to help parents of teenagers who are hospitalized due to thoughts of suicide, suicide attempts, or self-harming behaviors. The goal is to see if providing parents with coaching—like teaching them safety planning and parenting skills—can improve their child's recovery compared to standard care. Parents will either participate in this coaching program or continue with the usual treatment their child receives while in the hospital. The researchers hope that by supporting parents, the teenagers may have better outcomes regarding their mental health and safety.
To be eligible for the study, the teenager must be between the ages of 12 and 18, currently hospitalized for suicidal thoughts or attempts, and have at least one parent or guardian willing to take part. It’s important that both the parent and teenager can communicate well in English. Participants can expect to engage in the coaching sessions during the hospital stay, which will also include help connecting to further care after discharge. This trial is currently recruiting participants and aims to gather important information that could help improve future treatments for youth facing these serious challenges.
Gender
ALL
Eligibility criteria
- Inclusion criteria are:
- • youth is currently hospitalized on the Stanford unit at Mills Peninsula Medical Center, on the Inpatient Adolescent Psychiatry Unit, for suicidal ideation and/or a suicide attempt.
- • youth is between the ages of 12-18 (18 year-old youth must still be in high school and living at home with parents for the duration of the study)
- • at least one parent/guardian is willing to participate in the study intervention
- • youth and parent speak English well enough to complete study treatment and assessments in English
- Exclusion criteria are:
- • • the youth or parent has a psychiatric or medical condition that would interfere with their ability to participate in study assessments and/or treatment (such as acute psychosis, neurological impairment, malnutrition due to anorexia)
About Stanford University
Stanford University is a prestigious academic institution renowned for its cutting-edge research and innovation in healthcare and medicine. As a clinical trial sponsor, Stanford leverages its extensive resources, including a collaborative network of world-class researchers and state-of-the-art facilities, to advance medical knowledge and improve patient care. The university is committed to conducting rigorous, ethical research that adheres to the highest standards of scientific integrity, fostering an environment where groundbreaking discoveries can translate into effective clinical applications. Through its clinical trials, Stanford aims to address critical health challenges and contribute to the development of novel therapies and treatment strategies.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Palo Alto, California, United States
Stanford, California, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials